Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jul 20, 2025

Biofunctionalization of Magnetic Nanomaterials

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

Engineering Platelet Membrane Imitating Nanoparticles for Targeted Therapeutic Delivery.

Shradha B Adhalrao¹, Kisan R Jadhav¹, Prashant L Patil¹

¹Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Sector 8 CBD Belapur, Navi Mumbai - 400614, Maharashtra, India.

Current Pharmaceutical Biotechnology

|August 4, 2023

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Requirement of artificial intelligence technology awareness for thoracic surgeons.

The cardiothoracic surgeon·2024

Same author

Engineered Bacteria: General Overview as Therapeutic Agent and a Novel Drug Delivery System.

Current pharmaceutical biotechnology·2022

Same author

Microbubbles Contrast Agents: General Overview as Diagnostics and Therapeutic Agent.

Current drug targets·2022

Same author

Cardiac Computed Tomography as a Diagnostic Modality for the Assessment of Complex Congenital Heart Disease Management.

Cureus·2021

Same author

Simultaneous multiple organ involvement with hydatid cyst: left lung, liver and pelvic cavity.

BMJ case reports·2021

Same author

BCS class II drug loaded protein nanoparticles with enhanced oral bioavailability: <i>in vitro</i> evaluation and <i>in vivo</i> pharmacokinetic study in rats.

Drug development and industrial pharmacy·2020

Platelet Membrane Imitating Nanoparticles (PMINs) offer a novel drug delivery system by mimicking platelet membranes for targeted therapy. These nanoparticles enhance drug efficacy and reduce side effects in conditions like cancer and atherosclerosis.

Area of Science:

Biomaterials Science
Nanotechnology
Drug Delivery Systems

Background:

Platelets play crucial roles in physiological processes and pathological conditions like cancer and atherosclerosis.
Platelet Membrane Imitating Nanoparticles (PMINs) leverage platelet membrane structure and function for advanced drug delivery.
Current drug delivery systems face challenges in targeting specificity and reducing off-target effects.

Purpose of the Study:

To prepare and characterize platelet membrane-like nanoparticles (PMINs).
To explore the advancements of PMINs in targeted therapy for various diseases.
To evaluate the potential of PMINs as a next-generation drug delivery platform.

Main Methods:

Engineering PMINs involves separating and purifying platelet membranes.

Keywords:

Platelet membrane imitating mimicking nanoparticles phototherapy.therapeutic delivery

More Related Videos

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants

Published on: August 5, 2021

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Related Experiment Videos

Last Updated: Jul 20, 2025

Biofunctionalization of Magnetic Nanomaterials

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants

Published on: August 5, 2021

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Therapeutic cargo is integrated into the platelet membrane.

The modified membrane is encapsulated within a nanoparticle scaffold.

Main Results:

PMINs exhibit high specificity in binding to target cells, reducing off-target effects.
The system successfully incorporates therapeutic agents for targeted delivery.
Characterization confirms the successful preparation of PMINs with potential therapeutic applications.

Conclusions:

PMINs represent a promising drug delivery system combining platelet membrane advantages with nanoparticle technology.
The ability to customize PMINs with specific cargo and surface markers opens new avenues for targeted medicine.
Further research and clinical trials are necessary to optimize PMINs for widespread therapeutic use.